Finance

Beta
Lists
PSH0:FRA
Sernova Biotherapeutics Inc
€0.065
-10.16%
(-0.0074) 1D
Jul 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PSH0...
Open
€0.07
High
€0.07
Low
€0.07
Mkt. cap
43.43M
Avg. vol.
2.16K
Volume
500.00
52-wk high
€0.14
52-wk low
€0.06
No. of employees
8
Open
€0.07
High
€0.07
Low
€0.07
Mkt. cap
43.43M
Avg. vol.
2.16K
Volume
500.00
52-wk high
€0.14
52-wk low
€0.06
No. of employees
8
News stories
From sources across the web
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.74M
809.63K
434.15K
444.87K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76M
1.59M
1.68M
1.85M
Operating expense
3.50M
2.40M
2.12M
2.30M
Total operating expenses
3.50M
2.40M
2.12M
2.30M
Operating income
-3.50M
-2.40M
-2.12M
-2.30M
Other non operating income
-
-
-
-
EBT including unusual items
-4.05M
-2.25M
-2.41M
-3.23M
EBT excluding unusual items
-4.10M
-2.26M
-2.41M
-3.23M
Income tax expense
21.12K
-54.97K
-72.00K
-
Effective tax rate
-0.52%
2.44%
2.99%
-
Other operating expenses
-
-
-
-
Net income
-4.07M
-2.20M
-2.33M
-3.23M
Net profit margin
-
-
-
-
Earnings per share
-0.01
-0.01
-0.01
-0.01
Interest and investment income
131.00
260.60K
-
413.00
Interest expense
-541.68K
-
-477.12K
-920.95K
Net interest expenses
-541.54K
260.60K
-477.12K
-920.53K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.40M
-2.34M
-2.11M
-2.29M
Gain or loss from assets sale
-50.96K
-4.25K
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more